Dr. Olfa Khalifa obtained her Master’s degree in Biology of Vascular Diseases from the faculty of Pharmacy of Montasir in Tunisia, in 2012 and a PhD in Genetics and Immunology from the University of Montpellier in France in 2016. As part of her work towards her doctorate, Dr. Khalifa investigated the role of new genes in rheumatoid arthritis. She is skilled in many molecular and cellular biology techniques including real time PCR, sanger sequencing, miRNA profiling, ACS, ELISA, cell culture, microarray, and other basic molecular biology techniques. Her Ph.D. work has been published in peer-reviewed international journals.

Dr. Khalifa joined QBRI in 2018 and is currently working with Dr. Arredouani. She is working on a project that investigates the molecular mechanisms that underlie the positive effect of GLP-1 agonist on non-alchoholic fatty liver disease.